A detailed history of Logan Capital Management Inc transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Logan Capital Management Inc holds 12,495 shares of RDY stock, worth $950,244. This represents 0.04% of its overall portfolio holdings.

Number of Shares
12,495
Previous 12,445 0.4%
Holding current value
$950,244
Previous $865,000 5.9%
% of portfolio
0.04%
Previous 0.04%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$67.36 - $77.59 $3,368 - $3,879
50 Added 0.4%
12,495 $916,000
Q4 2023

Feb 14, 2024

BUY
$64.27 - $69.9 $41,582 - $45,225
647 Added 5.48%
12,445 $865,000
Q2 2023

Aug 14, 2023

SELL
$53.34 - $63.11 $335,668 - $397,151
-6,293 Reduced 34.79%
11,798 $744,000
Q4 2022

Feb 14, 2023

SELL
$51.15 - $57.45 $66,290 - $74,455
-1,296 Reduced 6.68%
18,091 $936,000
Q3 2022

Nov 14, 2022

BUY
$49.9 - $57.32 $3,642 - $4,184
73 Added 0.38%
19,387 $1.02 Million
Q2 2022

Aug 11, 2022

SELL
$49.62 - $58.13 $38,008 - $44,527
-766 Reduced 3.81%
19,314 $1.07 Million
Q1 2022

May 16, 2022

BUY
$48.27 - $65.25 $240,529 - $325,140
4,983 Added 33.01%
20,080 $1.12 Million
Q4 2021

Feb 14, 2022

SELL
$59.5 - $67.25 $325,762 - $368,193
-5,475 Reduced 26.61%
15,097 $987,000
Q3 2021

Nov 12, 2021

BUY
$60.19 - $75.29 $266,160 - $332,932
4,422 Added 27.38%
20,572 $1.34 Million
Q2 2021

Aug 17, 2021

BUY
$62.12 - $74.2 $84,793 - $101,283
1,365 Added 9.23%
16,150 $1.19 Million
Q1 2021

May 14, 2021

SELL
$57.98 - $73.08 $3,014 - $3,800
-52 Reduced 0.35%
14,785 $907,000
Q4 2020

Feb 12, 2021

BUY
$62.61 - $71.29 $10,080 - $11,477
161 Added 1.1%
14,837 $1.06 Million
Q3 2020

Nov 13, 2020

BUY
$51.39 - $72.41 $204,532 - $288,191
3,980 Added 37.21%
14,676 $1.02 Million
Q1 2020

May 14, 2020

BUY
$34.75 - $45.85 $1,737 - $2,292
50 Added 0.47%
10,696 $431,000
Q4 2018

Feb 14, 2019

BUY
$31.89 - $38.44 $2,232 - $2,690
70 Added 0.66%
10,646 $401,000
Q2 2018

Aug 14, 2018

BUY
$28.49 - $35.06 $11,139 - $13,708
391 Added 3.84%
10,576 $341,000
Q1 2018

May 14, 2018

BUY
$31.93 - $39.54 $325,207 - $402,714
10,185 New
10,185 $333,000
Q4 2017

Feb 12, 2018

SELL
$34.15 - $37.62 $319,746 - $352,236
-9,363 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$30.11 - $37.72 $6,022 - $7,544
200 Added 2.18%
9,363 $334,000
Q2 2017

Aug 14, 2017

BUY
N/A
9,163
9,163 $386,000

Others Institutions Holding RDY

About DR REDDYS LABORATORIES LTD


  • Ticker RDY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 166,028,992
  • Market Cap $12.6B
  • Description
  • Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...
More about RDY
Track This Portfolio

Track Logan Capital Management Inc Portfolio

Follow Logan Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Logan Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Logan Capital Management Inc with notifications on news.